University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Department of Biochemistry and Molecular Biology: Summer Research

SURF Related Publications

Although 10 weeks is not a long time in terms of research, there are SURF students who are able to produce enough work to achieve authorship on manuscripts. Here is a sampling of SURF-related publications. The students are highlighted in bold.

  • Jun S-R, Boerma M, Udaondo Z, Richardson S, Thrall KD, Miousse IR, Seng J, Pathak R, Hauer-Jensen M. (2021) “Plasma metabolomics in a nonhuman primate model of abdominal radiation exposure.” Metabolites 11:540
  • Bostian, AC, Maddukuri, L, Reed, MR, Savenka, T, Hartman, JH, Davis, LE, Pouncey, DL, Miller, GP, Eoff, RL (2015) “Kynurenine signaling increases DNA polymerase kappa expression and promotes genomic instability in glioblastoma cells” Chem Res Tox, (2016) 29:101-8
  • Hartman, JH, Martin, HC, Caro, AA, Pearce AR, Miller, GP (2015) “Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates,” Toxicol 338:47-58.
  • Hartman, JH, Miller, GP, Boysen, G (2014) “Inhibitory Potency of 4-Carbon Alkanes and Alkenes toward CYP2E1 Activity,” Toxicol, 318:51-8.
  • Pugh, CP, Pouncey, DL, Hartman, JH, Nshimiyimana, R, Desrochers, LP, Goodwin, TE, Boysen G, Miller, GP (2014) “Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites,” Arch Biochem Biophys 564:244-53
  • Kovak MR, Saraswati S., Goddard, SD, Diekman AB (2013) Proteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomes. Andrology 1: 682-691. DOI: 10.1111/j.2047-2927.2013.00099.x.
  • Pawlowska, M, Chu, R, Fedejko-Kap, B, Augustin, E, Mazerska, Z, Radominska-Pandya, A, Chambers, TC. (2013) “Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.” Drug Metab Dispos 41:414-21.
  • Pianalto,KM, Hartman, JH, Boysen, G, Miller, GP (2013) “Differences in Butadiene Adduct Formation between Rats and Mice Not Due to Selective Inhibition of CYP2E1 by Butadiene Metabolites,” Toxicol Lett 223, 221-227. PMC3831829
  • Hartman, JH, Knott, AK, Miller GP (2013) “CYP2E1 Hydroxylation of Aniline Involves Negative Cooperativity,” Biochem Pharmacol 87, 523-33. PMID24345333
  • Byrum SD, Larson SK, Avaritt NL, Moreland LE, Mackintosh SG, Cheung W, Tackett AJ (2013) Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma. J Proteomics Bioinform, 6 (3), 43-50.
  • Hartman, JH, Bradley, AM, Laddusaw, RM, Perry Jr, MD, Miller, GP (2013) “Structure of Pyrazole Derivatives Impact their Affinity, Stoichiometry, and Cooperative Interactions for CYP2E1 Complexes.” Arch Biochem Biophys 537, 12-20. PMC3781954
  • Byrum, S, Smart, SK, Larson, SK, and Tackett, AJ (2012) Analysis of Stable and Transient Protein-Protein Interactions. Methods in Mol Biol, 833, 143-52.
  • Hartman, JH, Boysen, G, Miller, GP, (2012) “CYP2E1 Metabolism of Styrene Involves Allostery,” Drug Metab Dispos, 40:1976-83.
  • Ketkar A, Zafar MK, Banerjee S, Marquez VE, Egli M, Eoff RL (2012) A nucleotide-analogue-induced gain of function corrects the error-prone nature of human DNA polymerase iota. J. Am. Chem. Soc. 2012 Jun 27;134(25): 10698-705. Epub 2012 Jun 14
  • Jones DR, Kim SY, Guderyon M, Yun CH, Moran JH, Miller GP (2010) Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. Chem Res Toxicol. 2010 May 17;23(5):939-45.  [Abstract]
  • Elbein, AD, Pastuszak, I, Tackett, AJ, Wilson, T, Pan, YT (2010) The last step in the conversion of trehalose to glycogen:A mycobacterial enzyme that transfers maltose from maltose-1-phosphate to glycogen. J Biol Chem, in press.  [Abstract]
  • Ounpraseuth S, Rafferty TM, McDonald-Phillips RE, Gammill WM, Siegel ES, Wheeler KL, Nilsson EA, Cooney CA (2009) A Method to Quantify Mouse Coat-Color Proportions. PLoS ONE in press  [Abstract]
  • Collom, SL, Laddusaw, RM, Kuzmic, P, Burch, AM, Perry, Jr, MD, Miller, GP (2008) CYP2E1 Substrate Inhibition: Mechanistic interpretation through an effector site for monocyclic compounds. J Biol Chem, in press.  [Abstract]
  • Jamakhandi, AP, Kuzmic, P, Sanders, DA, Miller, GP (2007) Global Analysis of Protein-Protein Interactions Reveals Multiple CYP2E1-Reductase Complexes. Biochemistry 46, 10192-201.  [Abstract]
  • Collom, SL, Jamakhandi, AP, Tackett, AJ, Radominska-Pandya, A, and Miller, GP (2006) CYP2E1 active site residues in Substrate Recognition Sequence 5 identified by photoaffinity labeling and homology modeling. Archives Biochem Biophys, 459, 59-69.[Abstract]
  • Upreti, M, Lyle, CS, Skaug, B, Du, L, and Chambers, TC.  (2006) Vinblastine-induced apoptosis is mediated by discrete alterations in the subcellular distribution, oligomeric structure, and activation status of specific Bcl-2 family members.  J. Biol. Chem. 281, 15941-15950. [Abstract]
  • Kurmasheva RT, Peterson CA, Parham DM, Chen B, McDonald RE, Cooney CA. (2005) Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas. Pediatr Blood Cancer. 44:328-37. [Abstract]
  • Ebert RH II, Shammas MA, Sohal BH, Sohal RS, Egilmez NK, Ruggles S, Shmookler Reis RJ. (1996) Defining genes that govern longevity in Caenorhabditis elegans. Devel. Genet. 18:131-143. [Abstract]
  • Ebert RH II, Cherkasova VA, Dennis RA, Wu JH, Ruggles S, Eudy Perrin T, and Shmookler Reis RJ. (1993) Longevity-determining genes in Caenorhabditis elegans: Chromosomal mapping of multiple noninteractive loci. Genetics 135: 1003-1010. [Abstract]